NCT05343858

Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome

Pilot Study to Evaluate the Effect of the Consumption of Two Unicellular Microalgae (Chlorella Vulgaris and Arthrospira Platensis (Spirulina)) on Metabolic Syndrome Biomarkers in Overweight / Obese Subjects With Altered Lipid Profile

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Instituto de Investigación Hospital Universitario La Paz · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the effect of the consumption of two microalgae Chlorella vulgaris and Arthrospira platensis (Spirulina) on some biomarkers of metabolic syndrome: Total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, Apolipoprotein A and Apolipoprotein B, in overweight / obese subjects with altered lipid profile.

Detailed description

A randomized, parallel, and double-blind pilot study with 3 study arms is being performed to evaluate the effect of the consumption of two unicellular microalgae: Chlorella vulgaris and Arthrospira platensis (Spirulina). The investigators included 30 participants between 18 and 65 years (BMI ≥25 and \<40 kg / m2). All volunteers will be randomized into 3 study groups, and participants will receive the 3 different study products during 30 days.

Conditions

• Metabolic Syndrome

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Experimental: Group 1: Spirulina platensis	16 g/day (two doses of 8g)
DIETARY_SUPPLEMENT	Experimental: Group 2: Chlorella vulgaris	16 g/day (two doses of 8g)
DIETARY_SUPPLEMENT	Placebo Comparator: Group 3: Control	16 g/day (two doses of 8g)

Timeline

• Start date: 2019-09-09
• Primary completion: 2019-10-09
• Completion: 2021-01-31
• First posted: 2022-04-25
• Last updated: 2022-05-11

Locations

1 site across 1 country: Spain